Research in Social and Administrative Pharmacy
Volume 8, Issue 1 , Pages 17-35 , January 2012

New Zealand pharmacists’ alignment with their professional body’s vision for the future

References 

  1. Mesler MA. Boundary encroachment and task delegation: clinical pharmacists on the medical team. Sociol Health Ill. 1991;13:310–331
  2. Holloway SWF, Jewson ND, Mason DJ. ‘Reprofessionalization’ or ‘occupational imperialism’?: some reflections on pharmacy in Britain. Soc Sci Med. 1986;23:323–332
  3. Birenbaum A. Reprofessionalization in pharmacy. Soc Sci Med. 1982;16:871–878
  4. Commonwealth Government of Australia; Pharmacy Guild of Australia. The Fourth Community Pharmacy Agreement. Canberra (Australia): Australian Government, Department of Health and Aging; 2005;Available at: http://www.health.gov.au/internet/main/publishing.nsf/Content/F7FBDB333D030BFFCA2570C000003A44/$File/4cpacompilation.pdfAccessed 20.01.11.
  5. Department of Health. Pharmacy in the future: a vision for pharmacy in the new NHS. London (England): Department of Health; 2000;
  6. Department of Health. Pharmacy in the future: a vision for pharmacy in the new NHS. London (England): Department of Health; 2000;
  7. United States Government. Pharmacy Affairs and 340B Drug Pricing Program. Rockville, MD: US Dept of Health and Human Services; 2008;
  8. The Medicare Prescription Drug, Improvement and Modernization Act of 2003. Department UST, Trans; 2003;
  9. Department of Health. Pharmacy in England: building on strengths - delivering the future. London (England): HM Government, The Stationary Office; 2008;ISBN 9780101734127
  10. Commonwealth Government of Australia; Pharmacy Guild of Australia. The Fifth Community Pharmacy Agreement. Canberra (Australia): Australian Government, Department of Health and Aging; 2010;Available at: http://www.health.gov.au/internet/main/publishing.nsf/Content/C3DB799DB360AF0CCA25772000249FA8/$File/5CPA%20Agreement%2005%20August%202010.pdfAccessed 20.01.11
  11. Task Force on a Blueprint for Pharmacy. Blueprint for pharmacy: the vision for pharmacy. Ottawa (ON): Canadian Pharmacists Association; 2008;Available at: http://www.pharmacists.ca/content/about_cpha/whats_happening/cpha_in_action/pdf/BlueprintVision.pdfAccessed 20.01.11
  12. Tsuyuki R, Schindel TJ. Leading Change in Pharmacy Practice: Fully Engaging Pharmacists in Patient-Oriented Healthcare. Edmonton, Canada: COMPRIS, University of Alberta; 2004;
  13. Anonymous . A vision of pharmacy’s future roles, responsibilities, and manpower needs in the United States. American College of Clinical Pharmacy. Pharmacotherapy. 2000;20:991–1020
  14. Patel H. How the Pharmacy 2020 vision is lighting the way for pharmacy’s future. Pharm J. 2007;279:131–132
  15. Ministry of Health . New Zealand Primary Health Care Strategy. New Zealand Ministry of Health; 2001;
  16. Ministry of Health . Towards a Medicines Strategy. Wellington, New Zealand: Ministry of Health; 2006;
  17. Ministry of Health . New Zealand Medicines Strategy. Wellington, New Zealand: Ministry of Health; 2007;
  18. Pharmacy Sector Action Group . Focus on the future: ten-year vision for pharmacists in New Zealand. [Portable Document Format] Available at: http://psnz.org.nz/public/home/documents/10_yea_plan.pdfAccessed 06.12.10
  19. Kotter JP. Leading change: why transformation efforts fail. Harv Bus Rev. 1995;73:59–67
  20. In:  Graetz F,  Rimmer M,  Lawrence A,  Smith A editor. Managing Organisational Change. Milton, Australia: John Wiley & Sons; 2002;
  21. Scahill S, Harrison J, Sheridan J. The ABC of New Zealand’s ten year vision for pharmacists: awareness, barriers and consultation. Int J Pharm Pract. 2009;17:135–142
  22. Scahill S, Harrison J, Sheridan J. Pharmacy under the spotlight: New Zealand pharmacists’ perceptions of current and future roles and the need for accreditation. Int J Pharm Pract. 2010;18:59–62
  23. Teddlie C, Tashakkori A. Foundations of Mixed Methods Research: Integrating Quantitative and Qualitative Approaches in the Social and Behavioral Sciences. Thousand Oaks, CA: SAGE Publications, Inc.; 2009;
  24. Ministry of Health, Wellington, New Zealand . District Health Boards: frequently asked questions [webpage]. Available at: http://www.moh.govt.nz/moh.nsf/indexmh/dhb-faqAccessed 04.10.10
  25. Kotter JP, Schlesinger LA. Choosing strategies for change. Harv Bus Rev. 2008;86:130–139
  26. Roberts AS, Benrimoj SI, Chen TF, Williams KA, Hopp TR, Aslani P. Understanding practice change in community pharmacy: a qualitative study in Australia. Res Social Adm Pharm. 2005;1:546–564
  27. Bryant L. Evaluation of the Barriers to and Implementation of Comprehensive Pharmaceutical Care in New Zealand. Auckland, New Zealand: General Practice and Primary Health Care, University of Auckland; 2006;
  28. Bush J, Langley CA, Jesson JK, Wilson KA. Perceived barriers to the development of community pharmacy’s public health function: a survey of the attitudes of directors of public health and chief pharmacists in UK primary care organisations. Int J Pharm Pract. 2006;2:B68–B69
  29. Elvey R, Bradley F, Ashcroft D, Noyce P. Implementing medication usage reviews through the new community pharmacy contract: key drivers and barriers. Int J Pharm Pract. 2006;14(suppl 2):B32–B33
  30. Hall J, Smith I. Barriers to medicines use reviews: comparing the views of pharmacists and PCTs. Int J Pharm Pract. 2006;14(suppl 2):B51–B52
  31. Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P. Implementing cognitive services in community pharmacy: a review of facilitators used in practice change. Int J Pharm Pract. 2006;14:163–170
  32. Hopp TR, Sorensen EW, Herborg H, Roberts AS. Implementation of cognitive pharmaceutical services (CPS) in professionally active pharmacies. Int J Pharm Pract. 2005;13:21–31
  33. Van Mil JWF, De Boer WO, Tromp TFJ. European barriers to the implementation of pharmaceutical care. Int J Pharm Pract. 2001;9:163–168
  34. Lounsbery J, Green C, Bennett M, Pedersen CA. Evaluation of pharmacists’ barriers to the implementation of medication therapy management services. J Am Pharm Assoc (2003). 2009;49:51–58
  35. Snyder ME, Zillich AJ, Primack BA, et al. Exploring successful community pharmacist-physician collaborative working relationships using mixed methods. Res Social Adm Pharm. 2010;6(4):307–323
  36. McCann L, Hughes CM, Adair CG. A self-reported work-sampling study in community pharmacy practice: a 2009 update. Pharm World Sci. 2010;32:536–543
  37. Berbatis CG, Sunderland VB, Joyce A, Bulsara M, Mills C. Characteristics of Australia’s community pharmacies: National Pharmacy Database Project. Int J Pharm Pract. 2007;15:265–271
  38. Schommer JC, Pedersen CA, Gaither CA, Doucette WR, Kreling DH, Mott DA. Pharmacists’ desired and actual times in work activities: evidence of gaps from the 2004 National Pharmacist Workforce Study. J Am Pharm Assoc. 2006;46:340–347
  39. Doucette WR, Kreling DH, Schommer JC, Gaither CA, Mott DA, Pedersen CA. Evaluation of community pharmacy service mix: evidence from the 2004 National Pharmacist Workforce Study. J Am Pharm Assoc. 2006;46:348–355
  40. Schommer JC, Pedersen CA, Doucette WR, Gaither CA, Mott DA. Community pharmacists’ work activities in the United States during 2000. J Am Pharm Assoc. 2002;42:399–406
  41. Bell HM, McElnay JC, Hughes CM. A self-reported work sampling study in community pharmacy practice. Pharm World Sci. 1999;21:210–216
  42. Pronk MC, Blom LT, Jonkers R, Rogers EM, Bakker A, de Blaey KJ. Patient oriented activities in Dutch community pharmacy: diffusion of innovations. Pharm World Sci. 2002;24:154–161
  43. Midwest Pharmacy Workforce Research Consortium. Final report of the 2009 National Sample Survey of the Pharmacist Workforce to Determine Contemporary Demographic and Practice Characteristics. Paper presented at: Pharmacy Manpower Project, Inc.; March 1, 2010; Alexandria, VA.
  44. Martin J. Cultures in Organisations: Three Perspectives. 1st ed.. New York, NY: Oxford University Press; 1992;
  45. Pharmacy Council of New Zealand . Pharmacy Council of New Zealand Workforce Demographics Survey. Wellington, New Zealand: Pharmacy Council (NZ); 2007;
  46. Oppenheim A. Questionnaire Design, Interviewing and Attitude Measurement. London, UK: Pinter; 1992;
  47. Edmunds J, Calnan MW. The reprofessionalisation of community pharmacy? An exploration of attitudes to extended roles for community pharmacists amongst pharmacists and general practitioners in the United Kingdom. Soc Sci Med. 2001;53:943–955
  48. Adamcik BA, Ransford HE, Oppenheimer PR, Brown JF, Eagan PA, Weissman FG. New clinical roles for pharmacists: a study of role expansion. Soc Sci Med. 1986;23:1187–1200
  49. Bryant LJM, Coster G, Gamble GD, McCormick RN. General practitioners’ and pharmacists’ perceptions of the role of community pharmacists in delivering clinical services. Res Social Adm Pharm. 2009;5:347–362
  50. McDonald R, Cheraghi-Sohi S, Sanders C, Ashcroft D. Professional status in a changing world: the case of medicines use reviews in English community pharmacy. Soc Sci Med. 2010;71:451–458
  51. Scott A, Bond C, Inch J, Grant A. Preferences of community pharmacists for extended roles in primary care—a survey and discrete choice experiment. Pharmacoeconomics. 2007;25:783–792
  52. Cooksey JA, Knapp KK, Walton SM, Cultice JM. Challenges to the pharmacist profession from escalating pharmaceutical demand. Health Aff. 2002;21:182–188

PII: S1551-7411(10)00168-3

doi: 10.1016/j.sapharm.2010.12.001

Research in Social and Administrative Pharmacy
Volume 8, Issue 1 , Pages 17-35 , January 2012

Article Tools